|
1
|
Polyak K: Breast cancer: origins and
evolution. J Clin Invest. 117:3155–3163. 2007.
|
|
2
|
Bray F, McCarron P and Parkin DM: The
changing global patterns of female breast cancer incidence and
mortality. Breast Cancer Res. 6:229–239. 2004.
|
|
3
|
Downs-Holmes C and Silverman P: Breast
cancer: overview & updates. Nurse Pract. 36:20–26. 2011.
|
|
4
|
Sauer G, Körner R, Hanisch A, Ries A, Nigg
EA and Silljé HH: Proteome analysis of the human mitotic spindle.
Mol Cell Proteomics. 4:35–43. 2005.
|
|
5
|
Tsou AP, Yang CW, Huang CY, et al:
Identification of a novel cell cycle regulated gene, HURP,
overexpressed in human hepatocellular carcinoma. Oncogene.
22:298–307. 2003.
|
|
6
|
Silljé HH, Nagel S, Körner R and Nigg EA:
HURP is a Ran-importin beta-regulated protein that stabilizes
kinetochore microtubules in the vicinity of chromosomes. Curr Biol.
16:731–742. 2006.
|
|
7
|
Koffa MD, Casanova CM, Santarella R, et
al: HURP is part of a Ran-dependent complex involved in spindle
formation. Curr Biol. 16:743–754. 2006.
|
|
8
|
Yu CT, Hsu JM, Lee YC, et al:
Phosphorylation and stabilization of HURP by Aurora-A: implication
of HURP as a transforming target of Aurora-A. Mol Cell Biol.
25:5789–5800. 2005.
|
|
9
|
Sasai K, Parant JM, Brandt ME, et al:
Targeted disruption of Aurora A causes abnormal mitotic spindle
assembly, chromosome misalignment and embryonic lethality.
Oncogene. 27:4122–4127. 2008.
|
|
10
|
Wong J, Lerrigo R, Jang CY and Fang G:
Aurora A regulates the activity of HURP by controlling the
accessibility of its microtubule-binding domain. Mol Biol Cell.
19:2083–2091. 2008.
|
|
11
|
Wong J and Fang G: HURP controls spindle
dynamics to promote proper interkinetochore tension and efficient
kinetochore capture. J Cell Biol. 173:879–891. 2006.
|
|
12
|
Negrini S, Gorgoulis VG and Halazonetis
TD: Genomic instability - an evolving hallmark of cancer. Nat Rev
Mol Cell Biol. 11:220–228. 2010.
|
|
13
|
Bakhoum SF and Compton DA: Kinetochores
and disease: keeping microtubule dynamics in check! Curr Opin Cell
Biol. 24:64–70. 2012.
|
|
14
|
Fragoso MC, Almeida MQ, Mazzuco TL, et al:
Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of
poor outcome in adrenocortical tumors: validation in a Brazilian
cohort of adult and pediatric patients. Eur J Endocrinol.
166:61–67. 2012.
|
|
15
|
Chiu AW, Huang YL, Huan SK, et al:
Potential molecular marker for detecting transitional cell
carcinoma. Urology. 60:181–185. 2002.
|
|
16
|
Lakhani and Sunil R: WHO Classification of
Tumours of the Breast. 4th edition. International Agency for
Research on Cancer; Lyon, France: 2012
|
|
17
|
Singletary SE and Greene FL: Revision of
breast cancer staging: The 6th edition of the TNM Classification.
Seminars in Surgical Oncology. 21. Wiley Subscription Services,
Inc., A Wiley Company; 2003
|
|
18
|
Kuo TC, Chang PY, Huang SF, Chou CK and
Chao CC: Knockdown of HURP inhibits the proliferation of
hepacellular carcinoma cells via downregulation of gankyrin and
accumulation of p53. Biochem Pharmacol. 83:758–768. 2012.
|
|
19
|
Betz MJ and Beuschlein F: Diagnosis: Novel
molecular signatures for adrenocortical carcinoma. Nat Rev
Endocrinol. 5:297–299. 2009.
|
|
20
|
Huang YL, Chiu AW, Huan SK, et al:
Prognostic significance of hepatoma-up-regulated protein expression
in patients with urinary bladder transitional cell carcinoma.
Anticancer Res. 23:2729–2733. 2003.
|
|
21
|
Wang YC, Lee YH, Huang GC, et al: Enhanced
transformation and chemosensitivity of NIH3T3 cells transduced with
hepatoma upregulated protein. Biochem Biophys Res Commun.
340:244–249. 2006.
|
|
22
|
Zhao L, Qin LX, Ye QH, et al: KIAA0008
gene is associated with invasive phenotype of human hepatocellular
carcinoma - a functional analysis. J Cancer Res Clin Oncol.
130:719–727. 2004.
|
|
23
|
Chen X, Thiaville MM, Chen L, et al:
Defining NOTCH3 target genes in ovarian cancer. Cancer Res.
72:2294–2303. 2012.
|
|
24
|
Ye F, Tan L, Yang Q, et al: HURP regulates
chromosome congression by modulating kinesin Kif18A function. Curr
Biol. 21:1584–1591. 2011.
|
|
25
|
Zelnak AB: Clinical pharmacology and use
of microtubule-targeting agents in cancer therapy. Methods Mol Med.
137:209–234. 2007.
|
|
26
|
Jordan MA and Wilson L: Microtubules as a
target for anticancer drugs. Nat Rev Cancer. 4:253–265. 2004.
|
